Related Experiment Video
Updated: Apr 15, 2026

08:17
A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
15.7K
Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria
Hiroko Oshiro1, Kumiko Goi, Koshi Akahane
1Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.
Abstract:
A 9-year-old boy with paroxysmal nocturnal hemoglobinuria/aplastic anemia syndrome (PNH/AA) developed hemolytic crisis after receiving immunosuppressive therapy. Eculizumab dramatically relieved the signs and symptoms and then he safely underwent unrelated bone marrow transplantation, suggesting the feasibility and effectiveness of eculizumab before stem cell transplantation in children with PNH/AA in hemolytic crisis.

